Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Marshall Islands
Marshall Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.9% in 2024. ▼ Falling
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Marshall Islands, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Marshall Islands recorded 0.9% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 10.0% on the previous year and down 25.0% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Marshall Islands peaked at 1.5% in 2017 and was at its lowest, 0.9%, in 2024.
That places Marshall Islands 40th out of 247 countries with data for 2024, putting it in the top quarter.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.2% | — |
| 2016 | 1.4% | +16.7% |
| 2017 | 1.5% | +7.1% |
| 2018 | 1.5% | +0.0% |
| 2019 | 1.2% | -20.0% |
| 2020 | 1.2% | +0.0% |
| 2021 | 1.1% | -8.3% |
| 2022 | 1.0% | -9.1% |
| 2023 | 1.0% | +0.0% |
| 2024 | 0.9% | -10.0% |
Marshall Islands compared with similar countries
- Marshall Islands's 0.9% is above the median for upper middle income countries, which is 0.2%, 4.5× the median. (55 countries reporting)
- Marshall Islands's 0.9% is above the median for East Asia & Pacific, which is 0.6%, 1.5× the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.4% | 1.2% | 1.5% | 5 |
| 2020s | 1.0% | 0.9% | 1.2% | 5 |
Countries ranked near Marshall Islands
More development goals data for Marshall Islands
- Red List Index 0.8363 (2025)
- Number of refugees per 100,000 population, by country of origin 0 (2025)
- Manufacturing value added per capita 162.5 (2025)
- Infant deaths 18 (2024)
- Neonatal deaths 9 (2024)
- Alcohol consumption per capita (aged 15 years and older) within a 0.7036 (2024)
- Under-five deaths 22 (2024)
- Children moderately or severely stunted 1.2 (2024)
- Children moderately or severely overweight 0.2 (2024)
- DEC alternative conversion factor 1 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Marshall Islands?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Marshall Islands was 0.9% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Marshall Islands?
- The highest recorded value was 1.5% in 2017.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Marshall Islands?
- The lowest recorded value was 0.9% in 2024.
- How does Marshall Islands rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Marshall Islands ranks 40th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Marshall Islands?
- Over the last ten years it is down 25.0%. The long-run trend across the full record is falling.
- Where does this Marshall Islands data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).